Editors' Pick

Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease.

Wright JR, Deen QFahm E, Stevenson A, Telford-Cooke L, Parker C, Martin-Ruiz C, Steinert JR, Kalaria RN, Mukaetova-Ladinska EB
J Alzheimers Dis. 2022 Oct 11; 89(4):1483-1492. PMID: 36057826. Abstract